Product Images Alfuzosin Hydrochloride

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 10 images provide visual information about the product associated with Alfuzosin Hydrochloride NDC 64679-738 by Wockhardt Usa Llc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Structure - af79c4ba 4a37 4d0c ad25 a063834da83e 01

Structure - af79c4ba 4a37 4d0c ad25 a063834da83e 01

Figure 1 - af79c4ba 4a37 4d0c ad25 a063834da83e 02

Figure 1 - af79c4ba 4a37 4d0c ad25 a063834da83e 02

Figure 2 - af79c4ba 4a37 4d0c ad25 a063834da83e 03

Figure 2 - af79c4ba 4a37 4d0c ad25 a063834da83e 03

This is a chart displaying the mean change after 84 days of treatment with a placebo (N=167) and Alfuzosin Hydrochloride extended-release tablets (N=170). The vertical axis shows the mean change and the horizontal axis shows the number of days. The chart suggests that there is a statistically significant difference between the two treatments after 28 days.*

Figure 3 - af79c4ba 4a37 4d0c ad25 a063834da83e 04

Figure 3 - af79c4ba 4a37 4d0c ad25 a063834da83e 04

Figure 4 - af79c4ba 4a37 4d0c ad25 a063834da83e 05

Figure 4 - af79c4ba 4a37 4d0c ad25 a063834da83e 05

Figure 5 - af79c4ba 4a37 4d0c ad25 a063834da83e 06

Figure 5 - af79c4ba 4a37 4d0c ad25 a063834da83e 06

Not available.*

Figure 6 - af79c4ba 4a37 4d0c ad25 a063834da83e 07

Figure 6 - af79c4ba 4a37 4d0c ad25 a063834da83e 07

Not available.*

Figure 7 - af79c4ba 4a37 4d0c ad25 a063834da83e 08

Figure 7 - af79c4ba 4a37 4d0c ad25 a063834da83e 08

This seems to be the result of a clinical trial evaluating the mean change (in mUs) after treatment with Alfuzosin Hydrochloride extended-release tablets in comparison with a placebo (N=150 and N=151 respectively). The chart shows the days of treatment and the statistical significance (NS p>0.05).*

Label - af79c4ba 4a37 4d0c ad25 a063834da83e 09

Label - af79c4ba 4a37 4d0c ad25 a063834da83e 09

Alfuzosin Hydrochloride Extended-release Tablets, USP 10 mg is a prescription tablet medication. Each tablet contains Alfuzosin hydrochloride USP 10 mg. The usual dosage to be taken as per the prescription provided in the package. The medication should be protected from high temperatures and moisture. It is recommended to store in a tight light-resistant container as described in the USP. The tablets should be kept out of the reach of children. Each pack contains 30 tablets with NDC number 64679-738-01. It is manufactured by Wockhardt USA LLC at Parsippany, NJ 07064 USA. The tablet should be dispersed with the attached patient information leaflet. For more dosage information, see the package.*

Label - af79c4ba 4a37 4d0c ad25 a063834da83e 10

Label - af79c4ba 4a37 4d0c ad25 a063834da83e 10

This is a medication information sheet for Alfuzosin Hydrochloride Extended-release Tablets, USP 10mg. The usual dosage is available in the package insert. The tablets should be protected from light and moisture, and stored at a controlled room temperature. The medication is manufactured by Wockhartt USALLC and distributed by WockhardtUnited. The text also includes the NDC code, lot number, and manufacturing information. The medication is available in containers of 500 tablets and should be dispensed with a patient information leaflet by a pharmacist.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.